Pain Relief

Share

Cancer patients and cancer survivors shouldn't have to live in pain. Ensuring access to effective pain medications improves their long-term outcomes and enhances their quality of life. 

We are working in state legislatures and with the federal government to ensure that new laws and regulations are balanced, addressing problems with misuse and abuse of opioids, while making sure patients continue to have access to needed pain medication. 

Latest Updates

May 2, 2023
Virginia

Victory in the fight against cancer requires bold new public policies that promote cancer prevention, early detection of cancer, expanded access to quality, affordable health care. Lawmakers make many decisions that impact the lives of Virginians touched by cancer and their leadership is vital to defeating this disease. In 2023,

February 6, 2023
National

Ahead of the President’s State of the Union Address, the American Cancer Society Cancer Action Network (ACS CAN) is calling on the President to emphasize the need for continued bipartisan support for increased federal investment in the fight against cancer.

April 11, 2022
National

Washington, D.C.--Today ACS CAN filed comments with the Centers for Disease Control and Prevention regarding proposed clinical practice guidelines for prescribing opioids. Read the full comments

April 23, 2020
Maine

Victory in the fight against cancer requires bold new public policies that promote cancer prevention, early detection of cancer, and expand access to quality, affordable health care. Lawmakers make many decisions that impact the lives of Mainers touched by cancer and their leadership is vital to defeating this disease. In

Pain Relief Resources

In the fall of 2018 the House and Senate passed the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (the SUPPORT Act)1 – comprehensive legislation to address the opioid epidemic.

ACS CAN was pleased that CDC heeded our prior request to allow open public comment on the proposed CDC opioid prescribing guideline, but remains concerned about the content and implementation of the proposed guideline.

  •